# OrthoPediatrics Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/OrthoPediatrics Corp). ## Overview OrthoPediatrics Corp. is a U.S.-based medical device company focused on orthopedic products designed specifically for children. Its portfolio includes implants, surgical instruments, specialized braces, and orthotic and prosthetic clinic services used by pediatric orthopedic surgeons, orthotists, and related care providers in the United States and international markets. ## Products & services • Pediatric trauma and deformity implants • Scoliosis and spine systems • Specialty bracing products • Orthotic and prosthetic clinic services • Surgical instruments and implant sets • Pediatric sports medicine systems - **Surgical implants and instruments** (55%) — Anatomically appropriate implant systems and the instrument sets used in pediatric orthopedic procedures. - **Specialized bracing** (25%) — Custom and off-the-shelf pediatric braces, including scoliosis and growth-modulation products. - **Orthotic and prosthetic clinic services** (15%) — Clinic-based fitting and treatment services for children needing non-surgical orthopedic care. - **Other pediatric orthopedic products** (5%) — Adjunct systems such as sports medicine, spine, and specialty procedure-specific products. - Pediatric trauma and deformity implants - Scoliosis and spine systems - Specialty bracing products - Orthotic and prosthetic clinic services - Surgical instruments and implant sets - Pediatric sports medicine systems ## Customers The company sells primarily to pediatric orthopedic surgeons and the hospitals or medical facilities where they perform procedures. It also serves orthotists, physical therapists, and, in some cases, end customers directly through bracing and clinic-based care. Internationally, products are sold through distributors and sales agencies, while in selected markets the company uses direct sales to hospitals. - **Pediatric orthopedic surgeons** (primary) — Buy implant systems, instruments, and procedure-specific tools for trauma, deformity, scoliosis, and sports medicine cases. - **Hospitals and medical facilities** (primary) — Host consigned implant and instrument sets and purchase products when used or shipped, depending on market structure. - **Orthotists and physical therapists** (secondary) — Buy or fit bracing products and support non-surgical pediatric orthopedic treatment. - **Patients and families** (secondary) — Receive custom braces and clinic services, especially through the company's O&P clinics. - **International distributors and agencies** (primary) — Purchase or facilitate sales of implants and braces in overseas markets and manage local hospital relationships. - Pediatric orthopedic surgeons buying procedure-specific implant systems - Hospitals and children's medical centers using consigned inventory - Orthotists and physical therapists purchasing bracing solutions - Patients and families receiving fitted braces or clinic services - International distributors and sales agencies reselling to hospitals ## Geography OrthoPediatrics is headquartered in Warsaw, Indiana and sells in the United States and more than 75 countries internationally. The company has direct sales programs in selected markets such as the UK, Ireland, Australia, New Zealand, Canada, Belgium, the Netherlands, Italy, Germany, Switzerland, and Austria, and it operates warehouses and local entities in Europe and Australia to support distribution. Its manufacturing footprint includes in-house bracing production in Iowa, the UK, and Boston, while most implants and instruments are produced in the United States through contract manufacturing. - Headquartered in Warsaw, Indiana, United States - Sells in the U.S. and over 75 international countries - Direct sales in selected markets including Canada and parts of Europe - Warehouses in Germany and Australia support regional distribution - Bracing production in Iowa, the UK, and Boston ## Strategy The company is expanding its installed base of consigned implant and instrument sets to improve hospital coverage and increase procedure access. It is also broadening its pediatric orthopedic portfolio through research and development, product line extensions, and selective acquisitions, while extending its clinic network and international sales infrastructure. - **Expand consigned inventory coverage** (short-term) — Pediatric orthopedic procedures often require full implant sets on site before revenue can be realized. - **Broaden product portfolio** (medium-term) — A wider offering improves surgeon adoption and addresses more pediatric orthopedic conditions. - **Strengthen international distribution** (medium-term) — Local sales and warehouse presence improves service levels and market access outside the U.S. - **Expand O&P clinic network** (medium-term) — Clinic services deepen the company’s role in non-surgical pediatric orthopedic care. - Increase consigned implant and instrument sets in key markets - Expand direct sales and distribution infrastructure internationally - Launch new surgical systems and product line extensions - Grow the O&P clinic network for non-surgical pediatric care - Pursue partnerships and selective acquisitions to widen the market ## Risks The business depends on elective pediatric procedures, surgeon adoption, and hospital access, so disruptions in procedure volumes or reimbursement can affect demand. International operations add exposure to distributor credit risk, product returns, trade compliance, and foreign market execution, while the company’s inventory-heavy model requires careful management of consigned sets and working capital. - **Elective surgery volume disruption** [high] — Most products are used in elective pediatric procedures, so hospital postponements reduce utilization. - **Surgeon adoption and training risk** [high] — Products require surgeon familiarity and proper technique; weak adoption can limit sales growth. - **International credit and return risk** [medium] — Overseas customers may return products and some distributors are thinly capitalized. - **Regulatory and reimbursement risk** [high] — Medicaid and other payer changes can affect reimbursement for pediatric orthopedic procedures. - **Inventory and consignment risk** [medium] — The model requires substantial upfront investment in hospital consignment sets and inventory. - Elective procedure deferrals can reduce implant and brace usage - Surgeon training and adoption are critical to product acceptance - International distributors may return products or be thinly capitalized - Trade, import, export, and customs rules add compliance risk - Consigned inventory requires upfront capital and inventory control ## Accounting Revenue recognition depends on whether products are used in surgery, shipped to a customer, or fitted in a clinic, so timing can vary materially by channel. The company also relies on estimates for contractual reimbursement, discounts, price concessions, returns, and inventory held on consignment, which can affect reported revenue and cost of revenue. Seasonality is important because summer and holiday periods typically have higher pediatric procedure volumes, making quarterly comparisons uneven. - **Revenue recognition by channel** — Implants on consignment, shipped braces, and fitted clinic services - **Estimated contractual allowances and concessions** — Reported revenue and accounts receivable - **Consigned inventory accounting** — Inventory, cost of revenue, and gross margin - **Seasonality** — Revenue comparability across quarters - Consigned implant revenue recognized when the product is used in surgery - Bracing revenue generally recognized on shipment when title passes - Clinic revenue depends on fitting and acceptance by the patient - Payor reimbursement estimates affect clinic revenue and allowances - Seasonality creates higher revenue in summer and holiday periods --- *Last updated: 2026-04-29T04:43:16.222674+00:00*